TLR9-MyD88 + ODN2395
|
boosts cell growth, migration, invasion, and IL8 secretion [206] |
cfDNA sensing by TLR9
|
modulates anti-tumor immunity in response to chemotherapy [208] |
TLR9-NF-kB-Cyclin D1
|
stimulation of cell proliferation [207] |
promotes maturation and migration of DCs to lymph nodes [208] |
cGAS-STING overexpression
|
reduces intratumoral inflammatory cell infiltration [210] |
activates tumor-specific cytotoxic T cells [208] |
leads to poor prognosis [210] |
low expression of cGAS-STING
|
ameliorates inflammation [209] |
cGAS down-regulation
|
increases mortality [211] |
enhances apoptosis [209] |
cGAS-STING inhibition by NEAT1
|
promotes tumor growth [214] |
STING activation
|
improves the protective effects of immunotherapy [212] |
AIM2 cfDNA sensing
|
modifies mitochondrial dynamics [218,219] |
enhances T cell-mediated anti-tumor immunity [213] |
cfDNA containing secretome
|
favors to supportive peritumoral milieu [229] |
AIM2 (regardless of inflammasome activation)
|
favors tumor cell survival [100,215,216,217] |
horizontal DNA transfer
|
favors to supportive peritumoral milieu [227,228,230,231] |
NET deposition
|
displays cytotoxic effects [235,236] |
NET formation
|
enhances adhesion, invasion, immune escape [232] |
inhibits cell growth, migration, survival [235,236] |
serves as a scaffold and trapping element [234] |
induces apoptosis [235] |
NET + TLR4-TLR9-HMBG1
|
activates neutrophils [234] |
|
activates tumor cells [234] |